PBA
Paradigm Biocapital Advisors’s Apogee Therapeutics APGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.6M | Sell |
958,630
-3,077
| -0.3% | -$134K | 1.78% | 16 |
|
|
2025
Q1 | $35.9M | Sell |
961,707
-322,059
| -25% | -$12M | 1.65% | 14 |
|
|
2024
Q4 | $58.2M | Buy |
1,283,766
+581,949
| +83% | +$26.4M | 2.02% | 15 |
|
|
2024
Q3 | $41.2M | Buy |
701,817
+371,817
| +113% | +$21.8M | 1.39% | 22 |
|
|
2024
Q2 | $13M | Hold |
330,000
| – | – | 0.5% | 29 |
|
|
2024
Q1 | $21.9M | Buy |
+330,000
| New | +$21.9M | 0.77% | 27 |
|